The ‘Roadmap for Growth’ Life Sciences Event
Pharmaceutical
Mon, 05/02/2018 - 07:30
ReViral’s RV521 fusion inhibitor produces highly significant reduction in viral load and clinical symptoms
Thu, 01/02/2018 - 07:30
Cambridge, UK, 1st February 2018 / Sciad Newswire / Domainex Ltd, a privately-owned drug discovery services company, is p
Wed, 31/01/2018 - 16:30
London, UK, 31st January 2018 / Sciad Newswire / 2018 will be a transformative year for UK healthcare as pioneering genomics companies identify people’s risk of d
Thu, 25/01/2018 - 08:30
Ongar, UK, 25th January 2018 / Sciad Newswire / Selcia Limited, a leading global provider of custom radiolabelling and integra
Thu, 25/01/2018 - 07:30
Edinburgh, UK, 25th January 2018 / Sciad Newswire / Synpromics Ltd, the leader in gene control, announces a collaboration
Wed, 24/01/2018 - 07:30
London, UK, 24th January 2018 / Sciad Newswire / The RSA Group, a leading Life Sciences executive search firm, announced
Tue, 23/01/2018 - 07:30
Cambridge, UK, 23rd January 2018 / Sciad Newswire / Domainex Ltd, a privately-owned drug discovery services company, has
Wed, 17/01/2018 - 07:30
Company establishes U.S. subsidiary to expand operations
Mon, 08/01/2018 - 07:00
Cambridge, UK, 8th January 2017 / Sciad Newswire / Cypralis and Gilead Sciences, Inc.